medigraphic.com
SPANISH

Medicina Cutánea Ibero-Latino-Americana

ISSN 0210-5187 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2006, Number 5

<< Back Next >>

Med Cutan Iber Lat Am 2006; 34 (5)

Carbamazepine-induced porphyria cutanea tarda

Avilés IJA, Chavarría ME, Suárez FR, Lázaro OP, García ACR
Full text How to cite this article

Language: Spanish
References: 14
Page: 229-232
PDF size: 211.15 Kb.


Key words:

porphyria, carbamazepine, abnormalities drug-induced, hypertrichosis.

ABSTRACT

A 32 years-old woman, with eight-years long depression disease, treated with clonazepam, carbamazepine and rebuxetine, referred a skin erosions in the dorsum of her hands and facial hypertrichosis. She also referred an increase in the intensity of her urine coloring. The complementary exam sho-wed very high levels of porphyrines and coproporphyrines in 24-hour urine. When carbamazepine was withdrawn, clinical and metabolic recovery of her porphyria cutanea tarda become in few months. A carbamazepine-induced cutaneous porphyria diagnose was reported.


REFERENCES

  1. 1.Lázaro Ochaíta P. Dermatología. Texto y atlas. 3ª ed. Meditécnica S. A. Madrid. 2003, p. 569.

  2. 2.Fitzpatrick TB. Dermatology in general medicine. Fifth edition. McGraw-Hill, Boston. 1999; pp. 1783-1790.

  3. Ayala F, Santoianni P. Drug-induced cutaneous porphyria. Clin Dermatol 1993;11:535-539.

  4. 4.Doss M, Schafer HJ. Carbamazepine-induced acute porphyria syndrome. Lancet 1984;1: 1026.

  5. Holroyd S, Seward RL. Psychotropic drugs in acute intermittent porphyria. Clin Pharmacol Ther 1999;66:323-5.

  6. 6.Reynolds NC Jr, Miska RM. Safety of anti-convulsants in hepatic porphyrias. Neurology 1981;31:480-4.

  7. 7.McGuire GM, Macphee GJ, Thompson GG, Park BK, Moore MR, Brodie MJ. The effects of chronic carbamazepine treatment of haem biosynthesis in man and rat. Eur J Clin Pharmacol 1988;35:241-7.

  8. 8.Rapeport WG, Connell JC, Thompson GG, Moore MR, Brodie MJ. Effect of carbamazepine on haem biosynthesis in man. Eur J Clin Invest 1984;14:107-10.

  9. Leo RJ, Cannuli AR. Porphyria Cutanea Tarda Associated With Carbamazepine Treatment. Am J Psychiatry 1996;153:443-444.

  10. 10.Grieco A, Alfei B, Di Rocco P, Miele L, Biolcati G, Griso D, et al. Non-alcoholic steatohepatitis induced by carbamazepine and variegate porphyria. Eur J Gastroenterol Hepatol 2001;13:973-975.

  11. 11.Ruggian JC, Fishbane S, Demento FJ, Maesaka JK, Frei GL. Porphyria cutanea tarda in a patient on chronic ambulatory peritoneal dialysis. J Am Soc Nephrol 1996;7: 397-402.

  12. 12.D'Alessandro R, Rocchi E, Cristina E, Cassanelli M, Benassi G, Pizzino D, et al. Safety of valproate in porphyria cutanea tarda. Epilepsia 1988;29:159-162.

  13. 13.Gaida-Hommernick B, Rieck K, Runge U. Oxcarbazepine in focal epilepsy and hepatic porphyria: a case report. Epilepsia 2001; 42:793-5.

  14. 14.Suzuki A, Aso K, Ariyoshi C, Ishimaru M. Acute intermittent porphyria and epilepsy: safety of clonazepam. Epilepsia 1992; 33:108-11.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Cutan Iber Lat Am. 2006;34